Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/13/2024 | $24.00 | Overweight | Cantor Fitzgerald |
1/4/2023 | $15.00 | Hold → Buy | Needham |
11/8/2022 | Underperform → Mkt Perform | William Blair | |
8/17/2022 | $24.00 | Outperform | Credit Suisse |
5/17/2022 | $25.00 → $23.00 | Underweight → Neutral | JP Morgan |
2/24/2022 | $30.00 | Hold → Buy | Cross Research |
11/4/2021 | Neutral → Underweight | JP Morgan | |
11/4/2021 | Overweight → Neutral | JP Morgan |
Innovative industrial solution enables manufacturers to reduce carbon footprint by up to 89 percent, improves cost and efficiency Stratasys (NASDAQ:SSYS) announced today the launch of SAF ReLifeTM, an innovative software-based solution that transforms waste PA12 powder from other additive manufacturing (AM) technologies into high-quality parts. The SAF ReLife solution can efficiently repurpose waste PA12 powder from powder bed fusion printers, including high-speed sintering, SLS (selective laser sintering) and jetting build processes for use within the Stratasys H350 printer. This sustainable solution helps customers produce high-quality surface finished parts with powder that otherwise c
Software solution empowers Stratasys customers with real-time insights and enhanced connectivity for maximizing uptime Stratasys Ltd. (NASDAQ:SSYS), will unveil its GrabCAD® IoT Platform at Formnext 2024, a solution designed to transform how customers manage their 3D printing operations and optimize additive manufacturing productivity. Formnext will be held in Frankfurt, November 19-22. The GrabCAD® IoT Platform is immediately available to Stratasys customers with GrabCAD® Streamline Pro™ workgroup software, with new PolyJet J3/J5 Series™ printers and from Stratasys Customer Support. The solution is planned to be rolled out to other technologies in the future. The new GrabCAD IoT Platfor
Stratasys Ltd. (NASDAQ:SSYS) will release financial results for the third quarter ended September 30, 2024, on Wednesday, November 13, 2024. The Company plans to hold the conference call to discuss its third quarter 2024 financial results on Wednesday, November 13, 2024, at 8:30 a.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com; or directly at the following web address: https://event.choruscall.com/mediaframe/webcast.html?webcastid=xEC56y1o To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least
Stratasys Ltd. (NASDAQ:SSYS) will release financial results for the third quarter ended September 30, 2024, on Wednesday, November 13, 2024. The Company plans to hold the conference call to discuss its third quarter 2024 financial results on Wednesday, November 13, 2024, at 8:30 a.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com; or directly at the following web address: https://event.choruscall.com/mediaframe/webcast.html?webcastid=xEC56y1o To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least
Revenue of $138.0 million, compared to $159.8 million ($154.6 million net of divestments) in second quarter 2023, related to ongoing impact of current macroeconomic environment on customer capital equipment purchasing Year-over-year growth in recurring consumables revenue of 6.3% reflects continued strong printer utilization Improved GAAP gross margin by 230bps and non-GAAP gross margin by 50bps compared to second quarter 2023. GAAP net loss of $25.7 million, or $0.36 per diluted share, and non-GAAP net loss of $3.0 million, or $0.04 per diluted share $2.4 million in cash used in operations and negative free cash flow of $5.4 million Completes strategic review process and an
- Recently initiated a pre-clinical trial with CollPlant's rhCollagen-based regenerative breast implants, printed with Stratasys' Origin® 3D printer that are 200cc in volume - Breast implants could address a $3.0 billion market opportunity - Cash and cash equivalents balance as of June 30, 2024 was $18.9 million - Conference call to be held today at 10:00 a.m. U.S. EDT REHOVOT, Israel, Aug. 20, 2024 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced financial results for the second quarter
Medical facilities and device manufacturers previously limited by constraints can now create patient-specific models to enhance surgical preparation, elevate patient outcomes, and fast-track innovation Stratasys Ltd. (NASDAQ:SSYS) today announced the launch of its J5™ Digital Anatomy™ 3D printer, the latest innovation designed to address the growing demand for cost-effective, high-fidelity anatomical models. This Stratasys innovation is designed to enable hospitals, medical device manufacturers and research institutions to enhance patient outcomes, streamline operations and bring products to market faster. This press release features multimedia. View the full release here: https://www.bu
Appointment of Amir Kleiner will strengthen the connection between the Customer Success organization and the Operations and Supply Chain divisions Stratasys Ltd. (NASDAQ:SSYS) today announced the appointment of Amir Kleiner as Chief Operating Officer. The 12-year Stratasys veteran will lead the company's Global Operations, MIS, and Quality team, while continuing to manage the Customer Success team. The appointment is set to strengthen the connection between the Customer Success organization and the Operations and Supply Chain divisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240408469494/en/Amir Kleiner, Chief Operatin
Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced that it has appointed Aris Kekedjian as an independent member of the Company's Board of Directors, effective immediately. Mr. Kekedjian replaces Ziva Patir, who has decided to step down from the Company's Board following ten years of service as a director. With this appointment, the Board will continue to comprise eight directors, seven of whom are independent. Mr. Kekedjian is an established executive who brings more than 30 years of leadership expertise across business development, M&A and operations of complex cross-border businesses at scale. He currently serves as C
6-K/A - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
SC 13G/A - STRATASYS LTD. (0001517396) (Subject)
SC 13D - STRATASYS LTD. (0001517396) (Subject)
SC 13D/A - STRATASYS LTD. (0001517396) (Subject)
Cantor Fitzgerald initiated coverage of Stratasys with a rating of Overweight and set a new price target of $24.00
Needham upgraded Stratasys from Hold to Buy and set a new price target of $15.00
William Blair upgraded Stratasys from Underperform to Mkt Perform
Desktop Metal, Inc. (NYSE:DM) shares are trading higher after it inked a definitive deal with Nano Dimension Ltd. (NASDAQ:NNDM), under which, Nano Dimension will fully acquire Desktop Metal in an all-cash deal at $5.50 per share. The deal offers a 27.3% premium over Desktop Metal’s closing price and a 20.5% premium over the 30-day VWAP as of July 2, 2024, totaling approximately $183 million. The purchase price can be adjusted based on certain assumptions. If the deal extends into 2025, Nano Dimension will provide Desktop Metal a $20 million secured loan facility. Any draw on this facility before closing could adjust the purchase price by up to $0.80 per share. If all adjustments are ma
Craig-Hallum analyst Greg Palm maintains Stratasys (NASDAQ:SSYS) with a Buy and lowers the price target from $16 to $14.